Anaes · TIVA & target-controlled infusion
TIVA & target-controlled infusion (TCI)
Also known as TIVA · TCI · Propofol infusion · Marsh model · Schnider model · Effect-site targeting · Remifentanil TCI
TIVA and target-controlled infusion for the anaesthesia fellowship exams: how a TCI pump works, the propofol and remifentanil models, awareness and depth monitoring, when TIVA is chosen, pump safety and propofol infusion syndrome.
Checked against its sources on 23 Oct 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- An ongoing concern with TIVA is the increased incidence of unintended awareness; unlike volatile delivery, there is no end-tidal monitoring to confirm propofol delivery.
- Interruptions of anaesthetic delivery during movement from anaesthetic room to theatre contributed to accidental awareness at induction in NAP5.
- Syringes should be clearly labelled with content and drug concentration.
- Predicted propofol concentrations at loss of consciousness vary considerably across PK/PD models, so the model must be stated explicitly.
- Propofol infusion syndrome is associated with infusions above 4 mg/kg/h for more than 48 hours.
Meet the patient
A 28-year-old woman with a family history of malignant hyperthermia presents for elective laparoscopic surgery and receives a propofol-remifentanil TIVA. Halfway through the case her processed-EEG index drifts up to 70 and her heart rate climbs.
References15ShowHide
- [1]Pandit JJ, Andrade J, Bogod DG, et al. 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors Br J Anaesth, 2014.PMID 25204697
- [2]Taplin CF, et al. The quest for real time propofol monitoring: a review Anaesth Intensive Care, 2026.PMID 42290030
- [3]Sahinovic MM, et al. Clinical Pharmacokinetics and Pharmacodynamics of Propofol Clin Pharmacokinet, 2018.PMID 30019172
- [4]Schnider TW, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers Anesthesiology, 1998.PMID 9605675
- [5]Minto CF, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development Anesthesiology, 1997.PMID 9009935
- [6]Kam PC, et al. Propofol infusion syndrome Anaesthesia, 2007.PMID 17567345
- [7]Rüffert H, et al. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group Br J Anaesth, 2021.PMID 33131754
- [8]Végh T, et al. Pharmacology of thoracic anesthesia Curr Opin Anaesthesiol, 2026.PMID 41284736
- [9]Schaefer MS, et al. Total intravenous anesthesia vs single pharmacological prophylaxis to prevent postoperative vomiting in children: A systematic review and meta-analysis Paediatr Anaesth, 2017.PMID 29094418
- [10]Avidan MS, et al. Anesthesia awareness and the bispectral index N Engl J Med, 2008.PMID 18337600
- [11]Ye J, et al. A Prospective Study of Marsh PK-PD Model and Schnider PK-PD Model During Anesthesia Induction for Obese Patients Undergoing Elective Heart Surgery Pharmacol Res Perspect, 2026.PMID 42286797
- [12]Introna M, et al. Target concentrations of propofol predicted by four different pharmacokinetic/pharmacodynamic models to induce loss of consciousness in neurosurgical patients J Anesth Analg Crit Care, 2026.PMID 42231496
- [13]Zhou HH, et al. Comparison of isoflurane effects on motor evoked potential and F wave Anesthesiology, 2000.PMID 10861143
- [14]Stojanovic M, et al. What's new in intravenous anaesthesia? Curr Opin Anaesthesiol, 2026.PMID 41677226
- [15]Obara S, Kamata K, Nakao M, et al. Recommendation for the practice of total intravenous anesthesia. Journal of anesthesia, 2024.PMID 39217587